CA3116783C - Produit pharmaceutique cristallin de contezolid acefosamil, son procede de preparation et ses applications
- Google Patents
Produit pharmaceutique cristallin de contezolid acefosamil, son procede de preparation et ses applications
Info
Publication number
CA3116783C
CA3116783CCA3116783ACA3116783ACA3116783CCA 3116783 CCA3116783 CCA 3116783CCA 3116783 ACA3116783 ACA 3116783ACA 3116783 ACA3116783 ACA 3116783ACA 3116783 CCA3116783 CCA 3116783C
Authority
CA
Canada
Prior art keywords
crystal
complex
sodium
compound
crystal complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201811197435.4Aexternal-prioritypatent/CN111039984B/zh
Application filed by Shanghai Micurx Pharmaceutical Co LtdfiledCriticalShanghai Micurx Pharmaceutical Co Ltd
Publication of CA3116783A1publicationCriticalpatent/CA3116783A1/fr
Application grantedgrantedCritical
Publication of CA3116783CpublicationCriticalpatent/CA3116783C/fr
L'invention concerne un produit pharmaceutique cristallin de contezolid acéfosamil, son procédé de préparation et ses applications. L'invention concerne aussi un cristal composé ou un polymère cristallin de formule I, dans lequel R est sélectionné dans hydrogène, sodium ou une proportion quelconque dudit composé.
CA3116783A2018-10-152019-09-29Produit pharmaceutique cristallin de contezolid acefosamil, son procede de preparation et ses applications
ActiveCA3116783C
(fr)
Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin SV and 3-formylrifamycin S and a process of their preparation